Market revenue in 2024 | USD 32.2 million |
Market revenue in 2030 | USD 35.1 million |
Growth rate | 1.4% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.04% in 2024. Horizon Databook has segmented the Argentina hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
In Argentina, the market is led by global players such as Cepheid and Qiagen, alongside domestic companies such as Bioars. Global firms bring innovation through rapid molecular testing, while local companies focus on affordability and pathogen-specific diagnostics.
Recent developments include Cepheid's launch of GeneXpert systems targeting multidrug-resistant organisms. Competitive strategies include building partnerships with government programs to enhance diagnostics accessibility and investing in training for healthcare professionals to improve test utilization rates.
The National Administration of Drugs, Foods, and Medical Devices (ANMAT) regulates the HAI diagnostics market in Argentina. ANMAT's stringent approval processes, requiring local clinical validations, often delay market entry but ensure high product quality. Regulatory initiatives supporting AMR surveillance have spurred innovation in diagnostic assays.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account